Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
08/2012
08/30/2012US20120220759 Synthetic heparin disaccharides
08/30/2012US20120220631 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR
08/30/2012US20120220629 Asymmetric ureas and medical uses thereof
08/30/2012US20120220617 Fluorescent Perylene Derivatives for Direct Detection of Heparin
08/30/2012US20120220609 5-hydroxypyrimidine-4-carboxamide derivative
08/30/2012US20120220606 New capped pyrazinoylguanidine sodium channel blockers
08/30/2012US20120220587 Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
08/30/2012US20120220586 Heterocyclic compounds and their uses
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220575 N-substituted oxazinopteridines and oxazinopteridinones
08/30/2012US20120220567 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
08/30/2012US20120220563 Substituted piperidines
08/30/2012US20120220558 Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives
08/30/2012US20120220529 Nitric oxide-blocked cross-linked tetrameric hemoglobin
08/30/2012US20120220527 Methods and materials for reducing platelet counts and/or platelet adhesion
08/30/2012US20120219637 Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof
08/30/2012US20120219624 Process for preparing products comprising stabilised actives and compositions comprising same
08/30/2012US20120219619 Substances for reducing occurrence of major cardiac events in humans
08/30/2012US20120219612 Mineral Technologies (MT) for Acute Hemostasis and for the Treatment of Acute Wounds and Chronic Ulcers
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219558 Antagonists of pcsk9
08/30/2012US20120219555 Auto-antibody markers of autoimmune disease
08/30/2012US20120219554 Extracellular yaluronidase from streptomyces koganeiensis
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012US20120219514 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/30/2012CA2827923A1 Fc.gamma.riib-specific fc antibody
08/29/2012EP2492341A1 Multipotent nestin-positive cells
08/29/2012EP2492266A1 5-hydroxypyrimidine-4-carboxamide derivative
08/29/2012EP2492262A1 Fused heterocyclic compound and thrombopoietin receptor activator
08/29/2012EP2491036A2 Pyrazolopyrimidine derivatives
08/29/2012EP2490702A1 Treatment using reprogrammed mature adult cells
08/29/2012CN1841066B Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/29/2012CN102649787A (benzimidazole-2-yl)pyridine derivative and application thereof to preparation of anticoagulant medicines
08/29/2012CN102648978A Stable protein pharmaceutical preparation and preparation method thereof
08/29/2012CN102648975A Traditional Chinese medicine for treating primary thrombocytopenic purpura
08/29/2012CN102648970A Medicine composition for treating chronic aplastic anemia and preparation method thereof
08/29/2012CN102648932A Method for extracting alfalfa saponin
08/29/2012CN102648926A Method for extracting notoginsenoside and notoginseng total amino acid
08/29/2012CN102367229B Ethylenediamine diaceturate compound and pharmaceutical composition thereof
08/29/2012CN102228603B Chinese medicine for treating retention of urine
08/29/2012CN102225162B Medicine for enhancing leukocyte and thrombocyte of human body
08/29/2012CN102210783B Composition preparation of donkey-hide glue, and preparation method thereof
08/29/2012CN102180973B Target multifunctional anti-embolism fusion protein as well as preparation method and application thereof
08/29/2012CN102178679B Application of pyrroloquinoline quinone to the bone marrow hemopoietic function after recovery of radiation
08/29/2012CN102085205B Medical compound preparation of eugenol aspirin ester and method for preparing same
08/29/2012CN101946856B Compound Chinese medicine micro powder and fish food for fish disease control
08/29/2012CN101926458B Tea bag prepared from aerial part of hemlock parsley, preparation process and application thereof
08/29/2012CN101912601B Stabilised solid compositions of factor VII polypeptides
08/29/2012CN101791382B Chinese herbal medicine combination for treating nasal bleeding
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252739 Albumin fusion proteins
08/28/2012US8252302 Methods and compositions to treat hemorrhagic conditions of the brain
08/28/2012CA2492470C Stable pharmaceutical composition comprising erythropoietin
08/28/2012CA2437812C Compositions and methods for modulation of vascular structure and/or function
08/28/2012CA2434317C Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
08/28/2012CA2395589C Method for removing multimers of human serum albumin
08/28/2012CA2389345C Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/23/2012WO2012112232A1 METHODS AND COMPOSITIONS FOR TREATING β-THALASSEMIA AND SICKLE CELL DISEASE
08/23/2012WO2012112007A2 Composition containing inducer of sirt1 expression for preventing or treating sepsis or septic shock
08/23/2012WO2012110843A1 Methods and pharmaceutical compositions for promoting fibrinolysis and thrombolysis
08/23/2012WO2012110603A1 Novel sulfonaminoquinoline hepcidin antagonists
08/23/2012WO2012109743A1 Methods and compositions relating to coagulation assays
08/23/2012US20120214845 Active metabolite of a thrombin receptor antagonist
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
08/23/2012US20120214804 Pharmaceutical composition comprising indole compound
08/23/2012US20120214803 Novel Sulfonaminoquinoline Hepcidin Antagonists
08/23/2012US20120214799 Kinase inhibitors
08/23/2012US20120214792 Thieno- adn furo-pyrimidine modulators of the histamine h4 receptor
08/23/2012US20120214788 Heteroaryl-substituted piperidines
08/23/2012US20120214780 Substituted porphyrins
08/23/2012US20120214771 Compositions for treatment of cardiometabolic disorders
08/23/2012US20120214767 Tricyclic heterocyclic compounds
08/23/2012US20120214733 Oxytocin receptor agonists
08/23/2012US20120214729 Composition for preventing or treating inflammation
08/23/2012US20120213839 Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
08/23/2012US20120213838 Medical device for placement into a lumen and manufacturing method thereof
08/23/2012US20120213823 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012US20120213732 Targeted delivery of antiviral compounds through hemoglobin bioconjugates
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213730 Alteration of cell membrane for new functions
08/23/2012CA2810334A1 Methods and compositions relating to coagulation assays
08/22/2012EP2489667A1 Quinoxaline derivative
08/22/2012EP2489352A1 Medicaments for inhibiting thrombosis
08/22/2012EP2488486A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
08/22/2012EP2488026A1 The use of a par-1 antagonist in combination with a p2y12adp receptor antagonist for inhibition of thrombosis
08/22/2012EP2238128B1 Heterocyclic pyrazole-carboxamides as p2y12 antagonists
08/22/2012EP1876240B1 Anti-human platelet membrane glycoprotein vi monoclonal antibody
08/22/2012EP1507780B1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
08/22/2012CN102648212A Von willebrand factor (vWF)-containing preparations, and methods, kits, and uses related thereto
08/22/2012CN102647989A Treatment using reprogrammed mature adult cells
08/22/2012CN102647983A Prophylactic and/or therapeutic agent for dysmenorrhea
08/22/2012CN102643762A Brevibacillus parabrevis as well as method and application of protein series prepared thereby
08/22/2012CN102643735A Health wine and production technology thereof
08/22/2012CN102643256A Arylglucoside compound and preparation method and application thereof
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 671